These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31762813)

  • 41. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase.
    Xu W; Jiang H; Zhang F; Gao J; Hou J
    Oncol Lett; 2017 May; 13(5):3387-3394. PubMed ID: 28521444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
    Wang H; Li H; Zhang L; Yang D
    Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer.
    Wang X; Ghareeb WM; Zhang Y; Yu Q; Lu X; Huang Y; Huang S; Sun Y; Chi P
    J Cell Physiol; 2019 Aug; 234(10):18180-18191. PubMed ID: 30859572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A.
    Ma Y; Wang R; Lu H; Li X; Zhang G; Fu F; Cao L; Zhan S; Wang Z; Deng Z; Shi T; Zhang X; Chen W
    J Cancer; 2020; 11(8):2158-2170. PubMed ID: 32127943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin.
    Yao H; Sun Q; Zhu J
    Exp Ther Med; 2019 Jun; 17(6):4363-4370. PubMed ID: 31086572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway.
    Tian L; Zhao Z; Xie L; Zhu J
    Oncotarget; 2018 Jan; 9(4):4886-4896. PubMed ID: 29435149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells.
    Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Li Z; Wang H; Xu Z; Sun Y; Han J
    Oncol Rep; 2016 Mar; 35(3):1403-8. PubMed ID: 26750720
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients.
    Horak J; Dolnikova A; Cumaogullari O; Cumova A; Navvabi N; Vodickova L; Levy M; Schneiderova M; Liska V; Andera L; Vodicka P; Opattova A
    Front Oncol; 2022; 12():959407. PubMed ID: 36324569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.
    Amini-Farsani Z; Sangtarash MH; Shamsara M; Teimori H
    Cytotechnology; 2018 Feb; 70(1):203-213. PubMed ID: 28887606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.
    Ke TW; Wei PL; Yeh KT; Chen WT; Cheng YW
    Ann Surg Oncol; 2015 Aug; 22(8):2649-55. PubMed ID: 25515201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.
    Tong J; Shen Y; Chen X; Wang R; Hu Y; Zhang X; Zhang Z; Han L
    Oncol Rep; 2019 Oct; 42(4):1404-1412. PubMed ID: 31524278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.